Our results suggest that TRIM21 is a crucial suppressor of hepatic glucose and lipid metabolism disorders and insulin resistance and thus may serve as a molecular target for treating type 2 diabetes mellitus. Here, TRIM21 is linked to Disorder of lipid metabolism.